dystrophinopathy

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Use of a mobility device was associated with a 3.5-fold higher risk of depressed mood among males with dystrophinopathy.

Effect: decline; HR=3.53; CI: 95%CI=2.13,5.85

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16

Corticosteroid use was associated with a significantly higher risk of behavior problems among males with dystrophinopathy, with the hazard of behavior problems being 2.4 times higher during years in w

Effect: adverse; HR=2.35; CI: 95%CI=1.75,3.16